Position in LFCR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,983,571
-$8,616,372 QoQ
Shares Held
1,877,305
-1.6% QoQ
Ownership
5.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $19,747,889,781 across 67 Drug Manufacturers - Specialty & Generic names. LFCR ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
35,584,312 | $4,206,421,510 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
5,399,649 | $3,201,883,855 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
65,136,464 | $1,961,910,288 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
13,385,607 | $1,763,419,854 | |
| 5 | VTRS |
Viatris Inc
|
84,359,804 | $1,139,700,941 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
47,622,630 | $1,139,609,527 | |
| 7 | ALKS |
Alkermes plc.
|
28,314,410 | $1,001,197,527 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
8,183,193 | $620,695,182 |
All Filings in LFCR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,983,571 | 1,877,305 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,599,943 | 1,907,084 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,547,122 | 1,840,642 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $15,223,585 | 1,874,826 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,425,026 | 1,764,919 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $12,010,450 | 1,616,481 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $7,458,820 | 1,512,946 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||